Biochips enable the accurate, rapid, and high-throughput detection of DNA, RNA, polypeptides, proteins, cells, tissues, and other biological components, with great advantages in disease screening and early diagnosis.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

French diagnostics firm Novacyt announcedrecentlythat it has received CE marking for its Genesig BK virus (BKV) and Epstein-Barr virus (EBV) diagnostic kits, which are designed for use in post-transplantation and immunosuppressed patients. B

A cell-by-cell search for cardiac stem cells has come up empty, suggesting that previous studies hinting at the existence of cardiac stem cells were mistaken. More significantly, the absence of cardiac stem cells indicates that heart muscle

An innovative new medical instrumentation and biotechnology company known asDaxorjust published some exciting new data for their flagship technology, theBVA-100 blood volume analyzer. The new technology is designed to quantify circulating to

Oxford HighQ has received2.1 millionin seed funding to commercialize components of a quantum computing technology developed at Oxford University that can be used to develop improved chemical and nanoparticle sensing technologies. Oxford High

A long-awaited and massive study with major implications for the liquid biopsy market is slated to start next year. Earlier this week, GRAIL revealed that it would initiate its 50,000-patient SUMMIT study in early 2019. Ages of the patients

Brigham and Womens Hospital investigators are working on a test that could either diagnose or predict Alzheimers disease before symptoms appear. The investigators approach is in the December issue of Alzheimers Dementia. Tau proteins have lo

At the close of the 2014-2016 West Africa Ebola crisis, the Paul G. Allen Foundation identified diagnostic gaps as one of the major deficiencies that had contributed to the outbreaks spread. The standard diagnostic tests that exist are very

Imagine being a pediatric kidney transplant patient and having to miss school or extracurricular activities because of clinic appointments and routine blood tests. Now imagine being offered a take-home kit that has everything you and your ca

Biocartis announced it has entered into an agreement with AstraZeneca. The goal of the agreement will be to obtain faster lung cancer molecular diagnostic biomarker results in Europe. A prospective lung cancer study with the Idylla EGFR Mut

Becton Dickinson said today that the US Food and Drug Administration has granted 510(k) clearance for its BD Max enteric viral panel, a molecular diagnostic test for the detection and differentiation of pathogens that cause viral gastroenter